Michael Naesby Email & Phone Number

Alsace, France

Reinach, Switzerland

• Portfolio management of in-house product pipeline candidates, and evaluation of technical feasibility, risk analysis, strategic fit, time to market analysis, etc. Technical and strategic evaluation of patent portfolio relating to pipeline molecules• Development of in-house capabilities in the polyphenols space, including flavonoids and anthocyanins, and responsibility for Evolva’s share of two EU co-funded programs, BachBerry and Promys• Business proposals for internal and 3rd party… Show more • Portfolio management of in-house product pipeline candidates, and evaluation of technical feasibility, risk analysis, strategic fit, time to market analysis, etc. Technical and strategic evaluation of patent portfolio relating to pipeline molecules• Development of in-house capabilities in the polyphenols space, including flavonoids and anthocyanins, and responsibility for Evolva’s share of two EU co-funded programs, BachBerry and Promys• Business proposals for internal and 3rd party development projects, including technical feasibility, resourcing, timelines, risk analysis, IP landscape, etc. Show less

Reinach, Switzerland

• Successfully managed and completed joint venture between BASF and Evolva, elucidation of a biosynthetic pathway and construction of proto-type strains for production of an ergot alkaloid with potential in crop protection.

Reinach, Switzerland

• Upgrading Evolva’s core platform technology, adapting the approach towards targeted reconstruction of biosynthetic pathways to specific valuable target molecules. Technical implementation of new company focus from pharma to ingredients for food, health, and wellness.• Elucidation of biosynthetic pathways, identification and engineering of highly active enzymes, engineering of host metabolism for optimal expression of precursor molecules and increased tolerance to product, and small-scale… Show more • Upgrading Evolva’s core platform technology, adapting the approach towards targeted reconstruction of biosynthetic pathways to specific valuable target molecules. Technical implementation of new company focus from pharma to ingredients for food, health, and wellness.• Elucidation of biosynthetic pathways, identification and engineering of highly active enzymes, engineering of host metabolism for optimal expression of precursor molecules and increased tolerance to product, and small-scale fermentation. Show less

Allschwil, Switzerland

• Leading a team of scientists in Allschwil responsible for implementation and further optimization of Evolva’s core platform technology, and preparation of combinatorial gene libraries used for activity screening in two drug discovery programs• Hiring and training of scientific personnel in Allschwil, doubling scientific staff.• Hiring in Hyderabad (India) and joint responsibility for scientific operation of Evolva Biotech Pvt.

Allschwil, Switzerland

• Starting up Evolva laboratories in Switzerland, including re-design and refurbishment of old factory building in Allschwil (Basel), moving and reinstalling equipment from Denmark, approvals from local authorities, hiring and training of scientific staff• Establishing new lab facilities for Evolva Biotech Pvt. (founded February 2005) at the Indian Inst. Chem. Tech. in Hyderabad, India, and starting up the research activity.• Scientific support for negotiations of two research grants… Show more • Starting up Evolva laboratories in Switzerland, including re-design and refurbishment of old factory building in Allschwil (Basel), moving and reinstalling equipment from Denmark, approvals from local authorities, hiring and training of scientific staff• Establishing new lab facilities for Evolva Biotech Pvt. (founded February 2005) at the Indian Inst. Chem. Tech. in Hyderabad, India, and starting up the research activity.• Scientific support for negotiations of two research grants awarded to Evolva by the US Defence Treat Reduction Agency (DTRA) in November 2006 Show less

Copenhagen Area, Denmark

• Development of yeast based HTS platform (FACS) for APIs. Responsible for development of Evolva’s proprietary technology for screening of novel, pharmaceutically active small molecules, based on yeast artificial chromosomes• Sourcing of several thousand eukaryotic tissue samples, extracting the genetic material, and creating normalized cDNA libraries used to prepare large gene expression libraries• As member of start-up core team (5 people), securing investment of CHF 18.6 mio first… Show more • Development of yeast based HTS platform (FACS) for APIs. Responsible for development of Evolva’s proprietary technology for screening of novel, pharmaceutically active small molecules, based on yeast artificial chromosomes• Sourcing of several thousand eukaryotic tissue samples, extracting the genetic material, and creating normalized cDNA libraries used to prepare large gene expression libraries• As member of start-up core team (5 people), securing investment of CHF 18.6 mio first round venture capital financing, triggering the move of Evolva to Switzerland Show less

Copenhagen Area, Denmark

Setting up laboratory facilities from scratch, leading the project focused on development of whole cell (E. coli) biosensors for diagnostic application.